Secondly, significant weight loss achieved with Wegovy may affect thyroid hormone requirements
3.1 Clinical trial landscape: observations on effect size and heterogeneity Currently, RCTs of GLP-1RAs in PCOS are generally characterized by small sample sizes, single-center designs, and relatively short follow-up periods
and grants/research support from Hanmi Pharmaceutical Co., Janssen Pharmaceuticals, Inc., Metavention, Novo Nordisk, Poxel SA, and Sanofi
When considering the combination of Retatrutide & Tesamorelin, it is vital to understand the distinct pathways each peptide influences
Check with your pharmacy about generic alternatives or other GLP-1 medications that might be more affordable or available